SEOUL (Reuters) – SK Bioscience has signed a letter of intent with Britain’s AstraZeneca for global production of its experimental COVID-19 vaccine, the South Korean company said on Tuesday.
South Korea’s health ministry will also participate in the cooperation, the company said in a statement.
(Reporting by Sangmi Cha; editing by Jason Neely)
